Russia's Vector Centre to Release 2 Variants of COVID-19 Vaccine Into Commercial Turnover

PETROPAVLOVSK-KAMCHATSKY, Russia (Sputnik) - Russia’s Vector research centre plans to release two variants of a COVID-19 vaccine into circulation, said director of the centre Rinat Maksyutov. "We have developed vaccines for the prevention of COVID-19 on the basis of six independent technological platforms. We have chosen two most promising vaccine options that we intend to release into civic circulation," Maksyutov said in a television appearance on Russia's Rossiya-1 channel. He went on to posit that some people may develop lifelong immunity under certain conditions. "With certain characteristics of the immune system, and if the course of the disease was severe, I can assume that lifelong immunity can be formed," Maksyutov said. The centre's vaccines are not far behind Russian Gamaleya research centre's Sputnik V, which was registered in August. Read more: https://sputniknews.com/business/202009261080579572-russias-vector-centre-to-release-2-variants-of-covid-19-vaccine-into-commercial-turnover/